629 related articles for article (PubMed ID: 19151627)
1. Immunoglobulin M deposition in cutaneous nerves of anti-myelin-associated glycoprotein polyneuropathy patients correlates with axonal degeneration.
Stalder AK; Erne B; Reimann R; Renaud S; Fuhr P; Thomann S; Arnold A; Probst A; Schaeren-Wiemers N; Steck AJ
J Neuropathol Exp Neurol; 2009 Feb; 68(2):148-58. PubMed ID: 19151627
[TBL] [Abstract][Full Text] [Related]
2. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy.
Lombardi R; Erne B; Lauria G; Pareyson D; Borgna M; Morbin M; Arnold A; Czaplinski A; Fuhr P; Schaeren-Wiemers N; Steck AJ
Ann Neurol; 2005 Feb; 57(2):180-7. PubMed ID: 15668968
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
[TBL] [Abstract][Full Text] [Related]
4. Severe cranial nerve involvement in a patient with monoclonal anti-MAG/SGPG IgM antibody and localized hard palate amyloidosis.
Yoshida T; Yazaki M; Gono T; Tazawa K; Morita H; Matsuda M; Funakoshi K; Yuki N; Ikeda S
J Neurol Sci; 2006 May; 244(1-2):167-71. PubMed ID: 16546215
[TBL] [Abstract][Full Text] [Related]
5. Immunofluorescence study of patients with neuropathy and IgM M proteins.
Takatsu M; Hays AP; Latov N; Abrams GM; Nemni R; Sherman WH; Nobile-Orazio E; Saito T; Freddo L
Ann Neurol; 1985 Aug; 18(2):173-81. PubMed ID: 2412485
[TBL] [Abstract][Full Text] [Related]
6. Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: a morphological study.
Nemni R; Galassi G; Latov N; Sherman WH; Olarte MR; Hays AP
Ann Neurol; 1983 Jul; 14(1):43-54. PubMed ID: 6311075
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
9. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody.
Mendell JR; Sahenk Z; Whitaker JN; Trapp BD; Yates AJ; Griggs RC; Quarles RH
Ann Neurol; 1985 Mar; 17(3):243-54. PubMed ID: 2581496
[TBL] [Abstract][Full Text] [Related]
10. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies.
Trojaborg W; Hays AP; van den Berg L; Younger DS; Latov N
Muscle Nerve; 1995 Jul; 18(7):730-5. PubMed ID: 7540258
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neuropathies associated with elevated IgM serum levels.
Goldfarb AR; Sander HW; Brannagan TH; Magda P; Latov N
J Neurol Sci; 2005 Feb; 228(2):155-60. PubMed ID: 15694197
[TBL] [Abstract][Full Text] [Related]
12. Local down-regulation of myelin-associated glycoprotein permits axonal sprouting with chronic nerve compression injury.
Gupta R; Rummler LS; Palispis W; Truong L; Chao T; Rowshan K; Mozaffar T; Steward O
Exp Neurol; 2006 Aug; 200(2):418-29. PubMed ID: 16764860
[TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.
Dalakas MC; Rakocevic G; Salajegheh M; Dambrosia JM; Hahn AF; Raju R; McElroy B
Ann Neurol; 2009 Mar; 65(3):286-93. PubMed ID: 19334068
[TBL] [Abstract][Full Text] [Related]
14. Anti-myelin-associated glycoprotein IgM antibody titers in neuropathy associated with macroglobulinemia.
Nobile-Orazio E; Francomano E; Daverio R; Barbieri S; Marmiroli P; Manfredini E; Carpo M; Moggio M; Legname G; Baldini L
Ann Neurol; 1989 Oct; 26(4):543-50. PubMed ID: 2479332
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
Magy L; Kaboré R; Mathis S; Lebeau P; Ghorab K; Caudie C; Vallat JM
J Immunol Res; 2015; 2015():450391. PubMed ID: 26065001
[TBL] [Abstract][Full Text] [Related]
16. Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing.
Lunn MP; Crawford TO; Hughes RA; Griffin JW; Sheikh KA
Brain; 2002 Apr; 125(Pt 4):904-11. PubMed ID: 11912122
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory demyelinating polyneuropathy.
Rizzuto N; Simonati A
Int J Tissue React; 1985; 7(6):521-6. PubMed ID: 4086221
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal IgM gammopathy with anti-myelin associated glycoprotein (MAG) activity and polyneuropathy. A study of three cases.
Sindic CJ; Boucquey D; Bisteau M; Laloux P; Brucher JM; Laterre C
Acta Neurol Belg; 1989; 89(5):331-45. PubMed ID: 2483599
[TBL] [Abstract][Full Text] [Related]
19. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening.
Ritz MF; Erne B; Ferracin F; Vital A; Vital C; Steck AJ
Muscle Nerve; 1999 Aug; 22(8):1030-7. PubMed ID: 10417783
[TBL] [Abstract][Full Text] [Related]
20. Peripheral nervous system and central nervous system pathology in rapidly progressive lower motor neuron syndrome with immunoglobulin M anti-GM1 ganglioside antibody.
Cai Z; Blumbergs PC; Koblar SA; Cash K; Manavis J; Ghabriel MN; Thompson PD
J Peripher Nerv Syst; 2004 Jun; 9(2):79-91. PubMed ID: 15104695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
